- Home
- PASG vs CELU Comparison
PASG vs CELU Comparison
Compare PASG & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PASG | CELU |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | United States |
| Employees | 27 | 115 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8M | 17.3M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PASG | CELU |
|---|---|---|
| Price | $4.94 | $0.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $14.00 | $6.00 |
| AVG Volume (30 Days) | 88.8K | ★ 89.8K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $76.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.29 | $0.56 |
| 52 Week High | $20.00 | $4.30 |
Technical Indicators
Market Signals| Indicator | PASG | CELU |
|---|---|---|
| Relative Strength Index (RSI) | 48.59 | 52.65 |
| Support Level | $4.25 | $0.69 |
| Resistance Level | $5.04 | $0.85 |
| Average True Range (ATR) | 0.30 | 0.06 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 82.72 | 61.76 |
Price Performance
Historical ComparisonAbout PASG Passage Bio Inc.
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
About CELU Celularity Inc.
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.